|
Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit of its results of financial year 2023 that ended on April 30. Cites unforeseen circumstances impacting the audit engagement team. Says audit is substantially complete without any material audit issues. Current stock price: 13.15 pence, down 6.1% on Friday 12-month change: up 6.2% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
